European multiple sclerosis market in dire need of increased disease awareness and treatment options, cautions Frost & Sullivan

Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis market.

Discovering biomarkers in relapsing remitting multiple sclerosis

UNIarray technology platform used for autoantibody research to support retrospective analysis of samples

Medical causes of multiple sclerosis

Despite intensive research, the factors that triggers multiple sclerosis and influences its progress remain unclear. Now, scientists have succeeded in attaining three important new insights into the disease.

Promise against multiple sclerosis

A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis.

Trophos launches first study of olesoxime in Multiple Sclerosis patients

Trophos SA announces the initiation of a phase 1b study of olesoxime in multiple sclerosis (MS) patients as a complementary therapy to their treatment with interferon beta.

Multiple sclerosis symptoms

A bodysuit that heats or cools a patient, combined with painless measurements of eye movements, helps to study the link between body temperature and MS symptoms.





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited